Spots Global Cancer Trial Database for pancreas adenocarcinoma
Every month we try and update this database with for pancreas adenocarcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| The Study of Gemcitabine Plus Nab-Paclitaxel in Combination With Pegvorhyaluronidase Alfa (PVHA; PEGPH20) and Pembrolizumab as Front-line Treatment for Metastatic Pancreatic Adenocarcinoma. | NCT04045730 | Pancreas Adenoc... | Gemcitabine | 18 Years - | Yale University | |
| Stereotactic Body Radiotherapy and Focal Adhesion Kinase Inhibitor in Advanced Pancreas Adenocarcinoma | NCT04331041 | Pancreas Cancer Cancer of the P... Pancreas Adenoc... | Adaptive stereo... Defactinib Tumor biopsy Research blood ... | 18 Years - | Washington University School of Medicine | |
| Assoc. of Genomic Polymorphisms With Cancer Cachexia in Subjects With Panc Adenocarcinoma | NCT05376592 | Pancreas Adenoc... Cachexia | 18 Years - | Wake Forest University Health Sciences | ||
| The Occurence of Pancreatic Cancer Studied in Association With Newly Diagnosed Diabetes in the Elderly | NCT04164602 | Diabetes Mellit... Diabetes Diabetes Mellit... Diabetes type2 Cancer of Pancr... Pancreas Neopla... Pancreas Adenoc... Pancreatic Canc... | 60 Years - | University of Pecs | ||
| Establishment of Pancreas Cancer and Cancer-associated Fibroblast Using EUS-guided Biopsy Samples | NCT05571956 | Pancreas Adenoc... | Pancreatic duct... | 20 Years - | Ajou University School of Medicine | |
| Study To Establish Maximum Tolerated Dose (MTD) of Cyberknife in Patients With Un-Resectable Pancreas Cancer (TL002) | NCT02707328 | Pancreas Cancer Pancreatic Canc... Adenocarcinoma ... Pancreas Adenoc... Pancreatic Aden... | Gemcitabine nab-paclitaxel CyberKnife | 18 Years - | The Cooper Health System | |
| Verification of Predictive Biomarkers for Pancreatic Cancer Treatment Using Multicenter Liquid Biopsy | NCT04241367 | Pancreas Adenoc... | - | National Cancer Center, Korea | ||
| Diagnostic Value of DWI-MRI for Detection of Peritoneal Metastases in High-risk Pancreatic Ductal Adenocarcinoma. | NCT05340569 | Pancreas Cancer... Pancreas Adenoc... Peritoneal Meta... Peritoneal Carc... | Whole-body diff... | 18 Years - | Laval University | |
| Diagnostic Value of DWI-MRI for Detection of Peritoneal Metastases in High-risk Pancreatic Ductal Adenocarcinoma. | NCT05340569 | Pancreas Cancer... Pancreas Adenoc... Peritoneal Meta... Peritoneal Carc... | Whole-body diff... | 18 Years - | Laval University | |
| EUS-guided Fine Needle Biopsy With a New Core Histology Needle Versus Conventional Fine Needle Aspiration | NCT01774162 | Pancreas Adenoc... Pancreas Neopla... Gastrointestina... Lymphoma | Fine needle bio... Fine needle asp... | 18 Years - | University of Alberta | |
| Study To Establish Maximum Tolerated Dose (MTD) of Cyberknife in Patients With Un-Resectable Pancreas Cancer (TL002) | NCT02707328 | Pancreas Cancer Pancreatic Canc... Adenocarcinoma ... Pancreas Adenoc... Pancreatic Aden... | Gemcitabine nab-paclitaxel CyberKnife | 18 Years - | The Cooper Health System | |
| Carbon Ions Radiation Therapy for Resectable or Borderline Resectable Pancreas Adenocarcinoma | NCT03822936 | Cancer of Pancr... Pancreas Adenoc... Resectable Panc... | Preoperative ch... Preoperative ra... | 18 Years - 75 Years | CNAO National Center of Oncological Hadrontherapy | |
| FLUOPANC-trial - Fluorescence-guided Surgery of Pancreatic and Bileduct Tumors Using cRGD-ZW800-1 | NCT05518071 | Pancreas Adenoc... Cholangiocarcin... | CRGD-ZW800-1 Intraoperative ... | 18 Years - | Leiden University Medical Center | |
| Neoadjuvant Folfirinox Combined With Pembrolizumab Followed by Surgery for Patients With Resectable Pancreatic Cancer | NCT05132504 | Pancreatic Duct... | Pembrolizumab Folfirinox | 18 Years - | Baylor College of Medicine | |
| EUS-guided Fine Needle Biopsy With a New Core Histology Needle Versus Conventional Fine Needle Aspiration | NCT01774162 | Pancreas Adenoc... Pancreas Neopla... Gastrointestina... Lymphoma | Fine needle bio... Fine needle asp... | 18 Years - | University of Alberta | |
| Endoscopic Ultrasound Guided Tissue Sampling (The SharkBITE Study) | NCT03532347 | Pancreas Cancer Pancreas Neopla... Chronic Pancrea... Pancreas Adenoc... | EUS-FNA needle ... | 18 Years - | Newcastle-upon-Tyne Hospitals NHS Trust | |
| Clinical Utility of Selected Circulating Tumor DNA Assays in Patients With Advanced Malignancy | NCT06290856 | Metastatic Colo... Pancreas Adenoc... Cholangiocarcin... | Multiplex PCR-t... | 18 Years - | Oslo University Hospital | |
| Analysis Of The Anxiety-Depressive Pattern, Quality Of Life And Assessment Of Personality in Patients With Pancreatic Ductal Adenocarcinoma (PACT24) | NCT04396093 | Pancreas Adenoc... | psychological s... | 18 Years - | IRCCS San Raffaele | |
| Carbon Ions Radiation Therapy for Resectable or Borderline Resectable Pancreas Adenocarcinoma | NCT03822936 | Cancer of Pancr... Pancreas Adenoc... Resectable Panc... | Preoperative ch... Preoperative ra... | 18 Years - 75 Years | CNAO National Center of Oncological Hadrontherapy | |
| A Study to Evaluate the Safety and Dosimetry of 68Ga-labelled OncoFAP Derivatives in Solid Tumors | NCT05784597 | Breast Cancer Colorectal Canc... Oesophageal Can... Pancreas Adenoc... | [68Ga]Ga-OncoFA... | 18 Years - 75 Years | Philogen S.p.A. | |
| The Role of the Human Microbiome in Patients After Pancreatic Resection. | NCT06381882 | Pancreas Cancer Pancreas Neopla... Pancreas Adenoc... Periampullary C... Periampullary C... Microbial Colon... | Pancreatic rese... | 18 Years - | St. Antonius Hospital | |
| The βIG-H3 Protein: a New Marker in PANCreatic Adenocarcinoma (BIGHPANC) | NCT03472716 | Pancreas Adenoc... | Biological Samp... | 18 Years - | Centre Leon Berard | |
| The βIG-H3 Protein: a New Marker in PANCreatic Adenocarcinoma (BIGHPANC) | NCT03472716 | Pancreas Adenoc... | Biological Samp... | 18 Years - | Centre Leon Berard | |
| Neoadjuvant Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma | NCT05825066 | Pancreas Adenoc... Borderline Rese... Locally Advance... | Nab paclitaxel Gemcitabine Radiological As... mFOLFIRINOX | 18 Years - | Wake Forest University Health Sciences | |
| Pancreatic Cancer Dietary Assessment Study | NCT03616431 | Pancreatic Neop... Pancreas Adenoc... Well-Differenti... Malignant Neopl... | Pancreo-KIT bre... | 18 Years - | The Christie NHS Foundation Trust | |
| Survival, Quality of Life and Resectability in Locally Advanced Pancreatic Cancer | NCT05356039 | Pancreas Cancer Pancreas Neopla... Pancreas Diseas... Pancreas Adenoc... Surgery Chemotherapy Ef... Quality of Life Locally Advance... Borderline Rese... | 18 Years - | Umeå University | ||
| Effect of Tumor Treating Fields (TTFields, 150 kHz) as Front-Line Treatment of Locally-advanced Pancreatic Adenocarcinoma Concomitant With Gemcitabine and Nab-paclitaxel (PANOVA-3) | NCT03377491 | Pancreas Adenoc... | NovoTTF-200T Gemcitabine nab paclitaxel | 18 Years - | NovoCure Ltd. | |
| A Study of Pre-Operative Cyberknife in Patients With Potentially Resectable Pancreas Cancer | NCT02707315 | Pancreas Cancer Pancreatic Canc... Adenocarcinoma ... Pancreas Adenoc... Pancreatic Aden... | Gemcitabine Stereotactic Ra... | 18 Years - | The Cooper Health System | |
| A Proof-of-Concept Study Evaluating LINFU™ | NCT05161013 | Pancreas Adenoc... Dysplasia | LINFU™ | 18 Years - 90 Years | Adenocyte, LLC | |
| A Study of Pre-Operative Cyberknife in Patients With Potentially Resectable Pancreas Cancer | NCT02707315 | Pancreas Cancer Pancreatic Canc... Adenocarcinoma ... Pancreas Adenoc... Pancreatic Aden... | Gemcitabine Stereotactic Ra... | 18 Years - | The Cooper Health System | |
| Improving Pancreatic Cancer Care by the Use of Computational Science and Technology | NCT06055010 | Pancreatic Canc... Pancreatic Cyst Pancreatic Aden... Pancreatic Dise... Pancreas Adenoc... Pancreas Cyst | No intervention... | - | UMC Utrecht | |
| Patient-derived Organoids Drug Screen in Pancreatic Cancer | NCT05351983 | Pancreas Cancer Pancreas Neopla... Pancreas Adenoc... Pancreatic Canc... Pancreatic Neop... Pancreatic Aden... | Surgical biopsy... | 18 Years - 100 Years | Klinik Hirslanden, Zurich | |
| Role of Perfusion CT in Pancreatic Cancer | NCT01703650 | Adenocarcinoma,... Neuroendocrine ... | iopromide CT | 18 Years - | Seoul National University Hospital | |
| PRECISE: Pancreatic Cancer and Exercise | NCT04305067 | Pancreas Adenoc... | Exercise | 18 Years - | Queen's University, Belfast | |
| Stereotactic Body Radiotherapy and Focal Adhesion Kinase Inhibitor in Advanced Pancreas Adenocarcinoma | NCT04331041 | Pancreas Cancer Cancer of the P... Pancreas Adenoc... | Adaptive stereo... Defactinib Tumor biopsy Research blood ... | 18 Years - | Washington University School of Medicine | |
| The Study of Gemcitabine Plus Nab-Paclitaxel in Combination With Pegvorhyaluronidase Alfa (PVHA; PEGPH20) and Pembrolizumab as Front-line Treatment for Metastatic Pancreatic Adenocarcinoma. | NCT04045730 | Pancreas Adenoc... | Gemcitabine | 18 Years - | Yale University | |
| Reinforced Staple Line on Leak Rate in Distal Pancreatectomy | NCT01359410 | Pancreatic Neop... | Mesh reinforced... Stapled without... | 18 Years - | Washington University School of Medicine | |
| Para-aortic Lymph Node Metastasis in Resectable Pancreatic Cancer | NCT06065891 | Pancreas Cancer Pancreas Adenoc... Lymph Node Meta... | PALN resection | 18 Years - | Uppsala University Hospital | |
| Digital Confocal Microscopy for Real-time Diagnosis of Pancreatic Solid Lesion | NCT06315439 | Pancreas Adenoc... Endoscopic Ultr... Digital Patholo... | Endoscopic ultr... | 18 Years - 90 Years | Campus Bio-Medico University | |
| Para-aortic Lymphnodes Removal During Upfront Pancreaticoduodenectomy | NCT04571294 | Pancreas Cancer Pancreaticoduod... Pancreas Adenoc... | removal of para... | 18 Years - | Humanitas Hospital, Italy | |
| Survival, Quality of Life and Resectability in Locally Advanced Pancreatic Cancer | NCT05356039 | Pancreas Cancer Pancreas Neopla... Pancreas Diseas... Pancreas Adenoc... Surgery Chemotherapy Ef... Quality of Life Locally Advance... Borderline Rese... | 18 Years - | Umeå University | ||
| Survival, Quality of Life and Resectability in Locally Advanced Pancreatic Cancer | NCT05356039 | Pancreas Cancer Pancreas Neopla... Pancreas Diseas... Pancreas Adenoc... Surgery Chemotherapy Ef... Quality of Life Locally Advance... Borderline Rese... | 18 Years - | Umeå University | ||
| Analysis Of The Anxiety-Depressive Pattern, Quality Of Life And Assessment Of Personality in Patients With Pancreatic Ductal Adenocarcinoma (PACT24) | NCT04396093 | Pancreas Adenoc... | psychological s... | 18 Years - | IRCCS San Raffaele | |
| Tumor Subtypes in Subjects on FOLFIRINOX With Non-Metastatic Pancreatic Cancer | NCT03977233 | Pancreatic Duct... Cancer of Pancr... Pancreatic Canc... Pancreas Adenoc... Pancreatic Neop... Pancreatic Canc... Pancreatic Canc... | Oxaliplatin Leucovorin Irinotecan Hydr... 5-FU | 18 Years - 99 Years | UNC Lineberger Comprehensive Cancer Center | |
| Evaluation of Clinical, Radiomics and Molecular Features of Lung Metastasis in PDAC Patients (LUMACA Trial) | NCT04435067 | Pancreas Adenoc... | Analysis of gen... Radiomics analy... | 18 Years - | IRCCS San Raffaele | |
| A SU2C Catalyst® Trial of a PD1 Inhibitor With or Without a Vitamin D Analog for the Maintenance of Pancreatic Cancer | NCT03331562 | Pancreatic Canc... Pancreas Adenoc... Advanced Pancre... Metastatic Panc... Metastatic Panc... | Pembrolizumab paricalcitol placebo | 18 Years - | Translational Genomics Research Institute | |
| Personalized Management of Pancreatic Adenocarcinoma Using Patient-Derived Tumoroids | NCT04821219 | Pancreas Adenoc... | Treatment predi... | 18 Years - | Mayo Clinic | |
| Pancreatic Cancer and Synchronous Liver Metastases Resection Following Neoadjuvant FOLFIRINOX | NCT06349278 | Pancreas Adenoc... Pancreas Metast... Pancreas Cancer | Pancreatic rese... | 18 Years - | Laval University | |
| A Study of Extended Total Mesopancreas Excision(eTME) for Pancreatic Head Adenocarcinoma. | NCT04147403 | Pancreas Adenoc... | - | Shanghai Jiao Tong University School of Medicine | ||
| Genetic Testing Decision Aid | NCT05470920 | Epithelial Ovar... Pancreas Adenoc... | Electronic Deci... Pre-Test Geneti... | 18 Years - | Massachusetts General Hospital | |
| Digital Confocal Microscopy for Real-time Diagnosis of Pancreatic Solid Lesion | NCT06315439 | Pancreas Adenoc... Endoscopic Ultr... Digital Patholo... | Endoscopic ultr... | 18 Years - 90 Years | Campus Bio-Medico University | |
| PRECISE: Pancreatic Cancer and Exercise | NCT04305067 | Pancreas Adenoc... | Exercise | 18 Years - | Queen's University, Belfast | |
| A SU2C Catalyst® Trial of a PD1 Inhibitor With or Without a Vitamin D Analog for the Maintenance of Pancreatic Cancer | NCT03331562 | Pancreatic Canc... Pancreas Adenoc... Advanced Pancre... Metastatic Panc... Metastatic Panc... | Pembrolizumab paricalcitol placebo | 18 Years - | Translational Genomics Research Institute | |
| Enfortumab Vedotin in Previously Treated Locally Advanced or Metastatic Pancreatic Cancer (EPIC) | NCT05915351 | Pancreatic Duct... Pancreas Adenoc... Pancreas Cancer | Enfortumab vedo... | 18 Years - | University of Kansas Medical Center | |
| CAPEcitabine eXtension of Adjuvant Therapy for Pancreatic Adenocarcinoma: (CAPE-X) | NCT06110598 | Pancreas Cancer Pancreas Adenoc... | Capecitabine | 19 Years - | Case Comprehensive Cancer Center | |
| Testing the Combination of Two Approved Chemotherapy Drugs and Radiation Prior to Surgery in Localized Pancreatic Cancer | NCT03492671 | Pancreas Adenoc... Resectable Panc... | Gemcitabine 100... nab-paclitaxel Stereotactic Bo... | 18 Years - | Loma Linda University | |
| Assoc. of Genomic Polymorphisms With Cancer Cachexia in Subjects With Panc Adenocarcinoma | NCT05376592 | Pancreas Adenoc... Cachexia | 18 Years - | Wake Forest University Health Sciences | ||
| Circulating Extracellular Exosomal Small RNA as Potential Biomarker for Human Pancreatic Cancer | NCT04636788 | Pancreas Adenoc... | Venous sampling | 18 Years - | Huazhong University of Science and Technology | |
| Tumor Subtypes in Subjects on FOLFIRINOX With Non-Metastatic Pancreatic Cancer | NCT03977233 | Pancreatic Duct... Cancer of Pancr... Pancreatic Canc... Pancreas Adenoc... Pancreatic Neop... Pancreatic Canc... Pancreatic Canc... | Oxaliplatin Leucovorin Irinotecan Hydr... 5-FU | 18 Years - 99 Years | UNC Lineberger Comprehensive Cancer Center | |
| Testing the Combination of Two Approved Chemotherapy Drugs and Radiation Prior to Surgery in Localized Pancreatic Cancer | NCT03492671 | Pancreas Adenoc... Resectable Panc... | Gemcitabine 100... nab-paclitaxel Stereotactic Bo... | 18 Years - | Loma Linda University |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
